Related Experiment Video
Updated: Dec 18, 2025

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
Published on: July 8, 2025
Patient-Reported Outcomes (PROs) in Acute Symptomatic Seizure (ASyS) Versus Patients With Established Epilepsy
Christopher R Newey1,2,3,4, Nicolas R Thompson5,6, Pravin George2,3,7
1Epilepsy Center, Cleveland Clinic, Cleveland, OH, USA.
Patients with acute symptomatic seizures (ASyS) experienced fewer seizures but reported worse quality of life compared to those with established epilepsy. Overall health outcomes improved over one year for both groups.
Area of Science:
- Neurology
- Critical Care Medicine
- Patient-Reported Outcomes
Background:
- Acute symptomatic seizures (ASyS) are common in critically ill patients.
- The impact of ASyS on posthospitalization health outcomes compared to established epilepsy is not well understood.
Purpose of the Study:
- To compare posthospitalization self-reported health in patients with ASyS versus those with established epilepsy.
- To analyze the trajectory of patient-reported outcomes over one year following hospitalization.
Main Methods:
- Retrospective cohort study (2010-2018) using an institutional epilepsy database.
- Collected patient-reported outcome measures (PROMs) including seizure frequency, Liverpool Seizure Severity Scale (LSSS), Quality of Life in Epilepsy (QOLIE)-10, PHQ-9, and PROMIS-GH.
- Utilized mixed-effects models adjusted for age, sex, and race to assess score changes over one year.
Main Results:
- 15,311 established epilepsy patients and 317 ASyS patients were analyzed.
- ASyS patients were older, predominantly male, more often Black, and had worse baseline QOLIE-10, PROMIS-GH Physical Health, and LSSS Ictal scores.
- Adjusted analysis showed ASyS patients had 38% fewer seizures but worse QOLIE-10 scores; all PROMs improved over time except PROMIS-GH Mental Health.
Conclusions:
- Patients with ASyS reported fewer seizures but a worse epilepsy-specific quality of life compared to patients with established epilepsy.
- Patient-reported outcomes generally improved over the one-year follow-up period for both groups.
- Findings highlight distinct posthospitalization health profiles for ASyS and established epilepsy patients.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...

